Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

[Evaluation of Photo- and Cytotoxicity of Chlorin e6 Ester Derivatives and Their Liposomal Forms].

Zorina TE, Yankovsky IV, Kravchenko IE, Shman TV, Belevtsev MV, Zorin VP.

Biofizika. 2015 Sep-Oct;60(5):922-30. Russian.

PMID:
26591603
2.

Frequencies of immature CD34 + CD38 - and CD34 + CD38-CD19 + blasts correlate with minimal residual disease level in pediatric B-cell precursor acute lymphoblastic leukemia.

Shman TV, Movchan LV, Aleinikova OV.

Leuk Lymphoma. 2013 Nov;54(11):2560-2. doi: 10.3109/10428194.2013.778404. Epub 2013 Apr 11. No abstract available.

PMID:
23432723
3.

Drug resistance associated properties of blasts subpopulations with different CD34 expression in childhood acute lymphoblastic leukemia (ALL).

Shman TV, Fedasenka UU, Savitski VP, Kustanovich AM, Aleinikova OV.

Exp Oncol. 2011 Sep;33(3):145-9.

PMID:
21956467
4.

ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.

Svirnovski AI, Shman TV, Serhiyenka TF, Savitski VP, Smolnikova VV, Fedasenka UU.

Hematology. 2009 Aug;14(4):204-12. doi: 10.1179/102453309X426218.

PMID:
19635183
5.

Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy.

Fedasenka UU, Shman TV, Savitski VP, Belevcev MV.

Exp Oncol. 2008 Sep;30(3):248-52.

PMID:
18806751
7.

CD34+ leukemic subpopulation predominantly displays lower spontaneous apoptosis and has higher expression levels of Bcl-2 and MDR1 genes than CD34- cells in childhood AML.

Shman TV, Fedasenka UU, Savitski VP, Aleinikova OV.

Ann Hematol. 2008 May;87(5):353-60. doi: 10.1007/s00277-008-0439-2. Epub 2008 Jan 29.

PMID:
18228020
8.

Apoptosis and proliferation differences between CD34+ and CD34- leukemic subpopulations in childhood acute leukemia.

Shman TV, Savitski VP, Fedasenka UU, Aleinikova OV.

Hematology. 2007 Oct;12(5):403-7.

PMID:
17852445
9.

Study of expression and functional activity of P-GP membrane glycoprotein in children with acute leukemia.

Shman TV, Savitskii VP, Potapnev MP, Aleinikova OV.

Bull Exp Biol Med. 2006 Jun;141(6):727-30. English, Russian.

PMID:
17364061
10.

[Drug sensitivity of tumor cells in varieties of acute childhood leukemia].

Shman TV, Belevtsev MV, Buglova SE.

Vopr Onkol. 2005;51(5):558-62. Russian.

PMID:
16756010
11.

Immunophenotypically heterogeneous acute T-lymphoblastic leukemia has invariable immunogenotype: analysis of two cases.

Meleshko A, Savitski VP, Shman TV, Aleinikova OV.

J Pediatr Hematol Oncol. 2006 Jan;28(1):50-2.

PMID:
16394895
12.

Comparative measurement of spontaneous apoptosis in pediatric acute leukemia by different techniques.

Savitskiy VP, Shman TV, Potapnev MP.

Cytometry B Clin Cytom. 2003 Nov;56(1):16-22.

13.

[Salvage thermochemotherapy in advanced refractory malignant tumors in children].

Ismail-zade RS, Buglova SE, Potapnev MP, Sachivko NV, Semenov AS, Rud'ko VS, Shman TV, Zhavrid EA.

Vopr Onkol. 2002;48(3):351-5. Russian.

PMID:
12455361
14.

Different Mechanisms of Resistance to Lymphokine-activated Killer (LAK) Cells in Leukemic Cell Sublines Selected by Etoposide or by LAK Cells.

Grinev VV, Grigorovich SA, Shman TV, Sheleg SV, Smolnikova VV, Potapnev MP, Svirnovski AI.

Hematology. 2001;6(5):321-9. doi: 10.1080/10245332.2001.11746586.

PMID:
27405526

Supplemental Content

Support Center